Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. A case-control study

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 5, 1998, Pages 239-242

  Snaedal, J ^a,b   Kristinsson, J ^a   Gunnarsdottir S ^a   Olafsdottir A ^a   Baldvinsson, M ^a   Johannesson T ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Reykjavik City Hospital   (Iceland)

Author keywords

Alzheimer's disease; Ceruloplasmin; Copper; Free radicals; Superoxide dismutase

Indexed keywords

CERULOPLASMIN; COPPER; FREE RADICAL; SUPEROXIDE DISMUTASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CERULOPLASMIN; COPPER; ERYTHROCYTES; FEMALE; FREE RADICALS; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; SUPEROXIDE DISMUTASE;

EID: 0031847561     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017067     Document Type: Article

References (21)

1. Evans PH: Free radicals in brain metabolism and pathology. Br Med Bull 1993;49:577-587.
2. Olanow CW, Arendash GW: Metals and free radicals in neurodegeneration. Curr Opin Neurol 1994;7:548-558.
3. Liu D, Yang R, Van X, McAdoo D: Hydroxy radicals generated in vivo kill neurons in the rat spinal cord: Electrophysiological, histological and neurochemical results. J Neurochem 1994; 62:37-44.
4. Smith JD: Apolipoprotein E allele-specific antioxidant activity and protection of a neuronal cell line. Alzheimer's disease: Advancing therapeutics towards the clinic. Cambridge Healthtech Institute's second conference, June 16-17, 1997, Washington, Congress Proceedings.
5. Goyer RA: Toxical effects of metals: in Klaassen CD (ed): Casarett and Doull's Toxicology. The Basic Science of Poisons, ed 5. New York, McGraw-Hill, 1996, p 715.
6. Andersen V, Toffe P: Kobber i drikkevand årsag til gastrointestinale symptomer (with English summary): Nord Med 1996;11:230-232.
7. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA: A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevence to Alzheimer's disease. Proc Natl Acad Sci USA 1994;91: 3270-3274.
8. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 2. Oxford, Clarendon Press. 1989, pp 44-46, 131-133, 254-255.
9. McKhann G, Drachman D, Folstein M, Katsman R, Price D, Stardlan M: Clinical diagnosis of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease. Neurology 1984;34:939-944.
10. Webster DD: Critical analysis of the disability in Parkinson's disease. Mod Treatm 1968;5: 257-282.
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
12. Boyett JD, Lehmann HP, Beeler MF: Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation. Acta Clin Chem 1976;69:233-241.
13. Nebot C, Moutet P, Huet P,Xu JZ, Yadan JC, Chaudiere J: Spectrophotometric assay of superoxide dismutase activity based on the activated autoxodation of a tetracyclic catechol. Anal Biochem 1993;214:442-451.
14. Basun H, Forsell LG, Wetterberg L, Winblad B: Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and Alzheimer's disease. J Neurol Transm 1991;4: 231-258.
15. Shore D, Henkin RI, Nelson NR, Agarwal RP, Wyatt RJ: Hair and serum copper, zink, calcium and magnesium concentrations in Alzheimer's type dementia. Am Geriatr Soc 1984; 32:892-895.
16. Kjeld M, Eldon J, Ólafsson Th: Copper- and zink concentration in serum. Lœknabladid 1987;73:335-338.
17. Loeffler DA, DeMaggio AJ, Juneau PL, Brickman CM, Mashour GA, Finkelman JH, Pomara N, LeWitt PA: Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not in Parkinson's disease. Alzheimer's Dis Assoc Disord 1994;3:190-197.
18. Connor JR, Tucker P, Johnson M, Snyder B: Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci Lett 1993;159:88-90.
19. Musci G, diPatti MCB, Fagiolo U, Calabrese L: Age related changes in human ceruloplasmin. J Biol Chem 1993;268:13388-13395.
20. deLustig ES, Serra JA, Kohan S, Canziani GA, Famulari AL, Dominiques RO: Copper-zink Superoxide dismutase activity in red blood cells and serum in demented patients and in aging. J Neurol Sci 1993;225:18-25.
21. Perrin R, Brian Von S, Jeandel C, Artur Y, Minn A, Penin F, Siest G: Blood activity of Cu/ Zn Superoxide dismutase, glutathion peroxidase and catalase in Alzheimer's disease: A case-control study. Gerontology 1990;36:306-313.